There are a lot of short sellers who are obligated to deliver TESLA shares in the future at a fixed price. Unless the stock tanks, they will be in trouble. In this case I don't see that the article writer disclosed any short interest, but I also didn't see any disclaimer of any interest of any sort.
The basic concept sounds like a win-win for everyone. GSK gets to save money and act like the good guy, while the poorest countries get inexpensive drugs. Obviously the devil is in the details, but I am at a loss to think of a better solution. If you want new drugs, then at least the richer countries must pay their part of the development costs (a great way to totally kill new drug development is to deny patents everywhere). GSK's solution is similar to a progressive drug development tax.
Personally, I think that the main reason why the Feds backed off is that they realized that if the all writs act ever gets to the Supreme Court, it is going down. Ironically a different part of the same 1789 judiciary act was declared unconstitutional by the Supreme Court in Marbury v. Madison (1803). This was the classic case where the Supreme Court struck down an act of Congress for the first time. Apple is an organization with enough power and credibility to take this case to the Supreme Court. So it made sense to back off and preserve the "validity" of the all writs act for future use.
Ironically, it may be Kik's attorneys that acted improperly here. Trademark law allows similar names to be reused for different fields of use, so long as there is not a possibility of confusion/loss of market. Here I seriously doubt that anyone would confuse a Javascript module with a chat application. So quite possibly this was a bogus assertion in the first place, which ended up causing serious damage to a lot of folks.
Instead of an "FDA for Data and Algorithms", I would recommend a non-government testing agency instead. Many of these exist already (think UL, "consumer reports", or European "notified bodies"). This requires that the industry agree on certain testing standards, and post on their websites when the algorithms have been certified. This could bring a lot of benefits without the drawbacks of government control.
And then, rather amazingly, after having presumably made the various KH-11 optics correctly, PerkinElmer somehow mysteriously did the main Hubble mirror optics wrong. I have always been suspicious of this...
A ruling like this could act as a major barrier against foreign companies of all sorts. For example, are service manuals or software updates covered? If so, this could act as a barrier against almost any imported manufactured product.
From Wikipedia: Laches (/lætz/, la-chz, like "latches";/letz/, lay-chz; Law French: "remissness", "dilatoriness," from Old French laschesse) refers to a lack of diligence and activity in making a legal claim, or moving forward with legal enforcement of a right, in particular with regard to equity; hence, it is an unreasonable delay that can be viewed as prejudicing the opposing [defending] party. When asserted in litigation, it is an equity defense, that is, a defense to a claim for an equitable remedy. The person invoking laches is asserting that an opposing party has "slept on its rights," and that, as a result of this delay, circumstances have changed, witnesses and/or evidence may have been lost or no longer available, etc., such that it is no longer a just resolution to grant the plaintiff's claim
After Lindbergh flew the Atlantic Ocean in the Spirit of Saint Louis in 1927, he didn't then turn around and fly back. Instead he sent the Spirit of Saint Louis back to the US by sea. It now resides in the Smithsonian. This particular SpaceX Falcon 9 rocket is historically important, and quite possibly may also end up in the Smithsonian some day.
Watto, the Mos Espa junk dealer, has already submitted the first bid. He has an employee working for him that is pretty good at refurbishing used equipment.
Commercial clinical analyzers are programmable by the end user. Thus, for example, it is possible for company "X" to purchase commercial clinical analyzers, put it's own programs on them, and say that "samples are being run on company X's proprietary systems". However if company X is also representing that it has proprietary clinical hardware, confusion might result. That is, a statement that "samples were run on company X's proprietary systems" would not enable outside readers determine if either commercial hardware or proprietary hardware was used. I am not sure if the press understands this.
Speaking as a fan of the actual Edgar Rice Burroughs "John Carter" books, I think that a big problem was that the Disney version was badly written. It felt as if they removed any sections where the book version of John Carter showed any intelligence, turned the heroine into a spoiled selfish brat, combined books 1 and 2 in a blender, and then filmed the result. Very painful to watch!
Yeah... Well he may have exposed problems in FDA regulations, but not in patent law. Daraprim (Pyrimethamine) has been available since 1953, and the patents expired 40-50 years ago. The drug is generic.
California better be careful with the definitions here. What exactly is "autonomous?" If written poorly, this could cover present day Tesla methods, or even older methods like cruise control that drive the car "autonomously" at a constant speed. If California wanted to ban this kind of thing, but wanted to be passive aggressive about it, would the draft read much differently?
Yahoo (present) renames it self to Acme Holdings, and spins off the Yahoo part as Yahoo. Presto! Yahoo now divested of non-Yahoo parts, and can even keep calling itself Yahoo. Acme Holdings then renames it self to whatever.
I am rather amazed that in a post-Snowden world, everyone is just totally fine with doing away with Thunderbird -- arguably one of the most important open source email systems out there. However I do understand why some large companies, such as Google (gmail) and Microsoft (outlook), might want to get rid of the competition. By the way, who is funding Mozilla these days?
A simple explanation of how Theranos managed to line-up Walgreens is that Theranos may have offered a large discount over standard lab pricing. But if, in fact, Theranos is running most of their tests on standard (or even slightly-tweaked standard) lab analyzers, how long can Theranos afford to operate at a large discount?
Unless they really have a big technological advantage over standard labs, which I doubt, then eventually Theranos is just another standard clinical lab operator, presumably operating at standard prices, and presumably valued at standard clinical lab valuations (much lower).
If he's going to be spending the entire year inside the ball, why not simplify? I see a hamster ball, lined with solar cells, battery, extra memory, and one or more video cameras. Add a satellite location beacon to pick up the ball afterwards.
Tesla seems to be adopting the "Wendy's strategy". Wendy's apparently sells excess hamburger as chili, thus somewhat compensating for daily swings in hamburger sales. Similarly Tesla is probably anticipating that their Gigafactory will also have unexpected swings in demand depending on vehicle sales and existing contracts with other battery suppliers.
By selling the excess Gigafactory battery production as battery based storage for homes, Tesla ensures two things: 1 - a better ramp up in Gigafactory utilization during the early years, and 2 - protection from unexpected swings in vehicle sales.
Slashdot Mirror
There are a lot of short sellers who are obligated to deliver TESLA shares in the future at a fixed price. Unless the stock tanks, they will be in trouble. In this case I don't see that the article writer disclosed any short interest, but I also didn't see any disclaimer of any interest of any sort.
The basic concept sounds like a win-win for everyone. GSK gets to save money and act like the good guy, while the poorest countries get inexpensive drugs. Obviously the devil is in the details, but I am at a loss to think of a better solution. If you want new drugs, then at least the richer countries must pay their part of the development costs (a great way to totally kill new drug development is to deny patents everywhere). GSK's solution is similar to a progressive drug development tax.
Personally, I think that the main reason why the Feds backed off is that they realized that if the all writs act ever gets to the Supreme Court, it is going down. Ironically a different part of the same 1789 judiciary act was declared unconstitutional by the Supreme Court in Marbury v. Madison (1803). This was the classic case where the Supreme Court struck down an act of Congress for the first time. Apple is an organization with enough power and credibility to take this case to the Supreme Court. So it made sense to back off and preserve the "validity" of the all writs act for future use.
So it is more of an unauthorized practice of law sort of thing...
Ironically, it may be Kik's attorneys that acted improperly here. Trademark law allows similar names to be reused for different fields of use, so long as there is not a possibility of confusion/loss of market. Here I seriously doubt that anyone would confuse a Javascript module with a chat application. So quite possibly this was a bogus assertion in the first place, which ended up causing serious damage to a lot of folks.
Instead of an "FDA for Data and Algorithms", I would recommend a non-government testing agency instead. Many of these exist already (think UL, "consumer reports", or European "notified bodies"). This requires that the industry agree on certain testing standards, and post on their websites when the algorithms have been certified. This could bring a lot of benefits without the drawbacks of government control.
Good thinking Maricopa County! Cue the lawsuits regarding disrespecting grand jury confidentiality in 3, 2. 1...
Good paranoia level = 0 explanation. Unfortunately I've been operating at paranoia level +1 level lately...
And then, rather amazingly, after having presumably made the various KH-11 optics correctly, PerkinElmer somehow mysteriously did the main Hubble mirror optics wrong. I have always been suspicious of this...
A ruling like this could act as a major barrier against foreign companies of all sorts. For example, are service manuals or software updates covered? If so, this could act as a barrier against almost any imported manufactured product.
From Wikipedia: Laches (/lætz/, la-chz, like "latches"; /letz/, lay-chz; Law French: "remissness", "dilatoriness," from Old French laschesse) refers to a lack of diligence and activity in making a legal claim, or moving forward with legal enforcement of a right, in particular with regard to equity; hence, it is an unreasonable delay that can be viewed as prejudicing the opposing [defending] party. When asserted in litigation, it is an equity defense, that is, a defense to a claim for an equitable remedy. The person invoking laches is asserting that an opposing party has "slept on its rights," and that, as a result of this delay, circumstances have changed, witnesses and/or evidence may have been lost or no longer available, etc., such that it is no longer a just resolution to grant the plaintiff's claim
After Lindbergh flew the Atlantic Ocean in the Spirit of Saint Louis in 1927, he didn't then turn around and fly back. Instead he sent the Spirit of Saint Louis back to the US by sea. It now resides in the Smithsonian. This particular SpaceX Falcon 9 rocket is historically important, and quite possibly may also end up in the Smithsonian some day.
Watto, the Mos Espa junk dealer, has already submitted the first bid. He has an employee working for him that is pretty good at refurbishing used equipment.
Commercial clinical analyzers are programmable by the end user. Thus, for example, it is possible for company "X" to purchase commercial clinical analyzers, put it's own programs on them, and say that "samples are being run on company X's proprietary systems". However if company X is also representing that it has proprietary clinical hardware, confusion might result. That is, a statement that "samples were run on company X's proprietary systems" would not enable outside readers determine if either commercial hardware or proprietary hardware was used. I am not sure if the press understands this.
Speaking as a fan of the actual Edgar Rice Burroughs "John Carter" books, I think that a big problem was that the Disney version was badly written. It felt as if they removed any sections where the book version of John Carter showed any intelligence, turned the heroine into a spoiled selfish brat, combined books 1 and 2 in a blender, and then filmed the result. Very painful to watch!
Yeah... Well he may have exposed problems in FDA regulations, but not in patent law. Daraprim (Pyrimethamine) has been available since 1953, and the patents expired 40-50 years ago. The drug is generic.
California better be careful with the definitions here. What exactly is "autonomous?" If written poorly, this could cover present day Tesla methods, or even older methods like cruise control that drive the car "autonomously" at a constant speed. If California wanted to ban this kind of thing, but wanted to be passive aggressive about it, would the draft read much differently?
Yahoo (present) renames it self to Acme Holdings, and spins off the Yahoo part as Yahoo. Presto! Yahoo now divested of non-Yahoo parts, and can even keep calling itself Yahoo. Acme Holdings then renames it self to whatever.
I am rather amazed that in a post-Snowden world, everyone is just totally fine with doing away with Thunderbird -- arguably one of the most important open source email systems out there. However I do understand why some large companies, such as Google (gmail) and Microsoft (outlook), might want to get rid of the competition. By the way, who is funding Mozilla these days?
A simple explanation of how Theranos managed to line-up Walgreens is that Theranos may have offered a large discount over standard lab pricing. But if, in fact, Theranos is running most of their tests on standard (or even slightly-tweaked standard) lab analyzers, how long can Theranos afford to operate at a large discount?
Unless they really have a big technological advantage over standard labs, which I doubt, then eventually Theranos is just another standard clinical lab operator, presumably operating at standard prices, and presumably valued at standard clinical lab valuations (much lower).
If he's going to be spending the entire year inside the ball, why not simplify? I see a hamster ball, lined with solar cells, battery, extra memory, and one or more video cameras. Add a satellite location beacon to pick up the ball afterwards.
Tesla seems to be adopting the "Wendy's strategy". Wendy's apparently sells excess hamburger as chili, thus somewhat compensating for daily swings in hamburger sales. Similarly Tesla is probably anticipating that their Gigafactory will also have unexpected swings in demand depending on vehicle sales and existing contracts with other battery suppliers.
By selling the excess Gigafactory battery production as battery based storage for homes, Tesla ensures two things: 1 - a better ramp up in Gigafactory utilization during the early years, and 2 - protection from unexpected swings in vehicle sales.
Oh sure, blame the Giant Asian Gerbils. What the heck? they're easy targets!
Finally, after 50+ years of sending astronauts into space, proof that when they return, they will still have their DNA. Send the news to John Glen!
You mean the G. W. O. U. S's? You keep using that word. I do not think it means what you think it means.